Concepedia

Rong Shi

RS

10

Publications

248

Citations

10

H-Index

2011

Active since

Affiliations

Roche (France)(Current)

Bristol-Myers Squibb (United States)

Shanghai University

Pfizer (United States)

Rong Shi is an author at Roche (France) specializing in medicine, pharmacotherapy, and oncology.

Top concepts

Publications per year

2011–2024

10

Publications

10

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects

Rong Shi, Marek Honczarenko, Sean X. Zhang et al. · The Journal of Clinical Pharmacology · 2016 · 43 citations · Full text

, , +20

Fixed Dosing Versus Body Size—Based Dosing of Therapeutic Peptides and Proteins in Adults

Shuzhong Zhang, Rong Shi, Chunze Li et al. · The Journal of Clinical Pharmacology · 2011 · 39 citations

Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma

Dan Lü, Tong Lu, Leonid Gibiansky et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 34 citations · Full text

, , +19

Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial

Yong Cai, Guoqiang Xing, Shen Tian et al. · Lipids in Health and Disease · 2017 · 31 citations · Full text

Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma

Tong Lu, Leonid Gibiansky, Xiaobin Li et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 24 citations · Full text

Rows per page

1–5 of 10